Valtech Cardio

Mitral Valve Repair Implants

Health Tech & Life Sciences
Acquired (Inactive) by Edwards Lifesciences on Jan 2017 - closed due to acquisition
Acquired Or Yehuda Founded 2005
LinkedIn
Total raised
$19.7M
Last: Series B 2010-03
Stage
Acquired
Founded
2005
Headcount
1-10
HQ
Or Yehuda
Sector
Health Tech & Life Sciences

About

Valtech Cardio specializes in the development of devices for mitral valve repair and replacement. The company's Cardinal facilitates implantation and suturing that is very similar to that of regular annuloplasty rings, performed through the left atrium. The Cardinal's ring is attached to a patented, ergonomically designed, flexible handle, which enables the surgeon to control the ring size. The V-Chordal system is an implantable, artificial chordae system that enables post-pump, echo-guided, chord length modification. This product offers a solution for an accuracy-dependent technique where sizing is critical. As of January 2017, Valtech Cardio is part of Edwards Lifesciences.

Funding history · 2 rounds · $19.7M total

2010-03
Series B $17.8M
2006-09
Undisclosed $1.9M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Valtech Cardio's primary specialization?
Valtech Cardio specializes in the development of devices for mitral valve repair and replacement.
When was Valtech Cardio founded?
Valtech Cardio was founded in January 2005.
What is the status of Valtech Cardio as of January 2017?
As of January 2017, Valtech Cardio was acquired by Edwards Lifesciences and is currently inactive.
What was the total amount raised by Valtech Cardio before its acquisition?
Valtech Cardio raised a total of $19,671,000 across its funding rounds.
Which investors participated in Valtech Cardio's Series B round?
NGN Capital and OXO Ventures participated in Valtech Cardio's Series B round in March 2010.
What was the acquisition amount for Valtech Cardio by Edwards Lifesciences?
Edwards Lifesciences acquired Valtech Cardio for $340,000,000 in January 2017.
Which company previously attempted to acquire Valtech Cardio in 2015?
HeartWare attempted to acquire Valtech Cardio for $860 million in September 2015, but the acquisition was canceled in January 2016.
What is one of Valtech Cardio's key products for mitral valve repair?
One of Valtech Cardio's key products is the Cardinal, which facilitates implantation and suturing of annuloplasty rings.
Who is a founder of Valtech Cardio?
Amir Gross is a founder of Valtech Cardio.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cardiologysurgeryvalvesmedical-devicesminimally-invasivehospitalssurgeonsdoctors